Assistant Director​/ Associate Director, Pharmaceutical Development

Headquartered in Carlsbad, California, and with offices in Boston, Massachusetts, and Dublin, Ireland, Ionis has been at work for more than three decades discovering medical breakthroughs that have redefined life for people with serious diseases. We’re pioneers in RNA-targeted medicines, and our platform continues to revolutionize drug discovery and transform lives for patients with unmet needs. With multiple marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient needs, we continue to drive innovation in RNA therapies in addition to advancing new approaches in gene editing to provide greater value to patients and are well positioned financially to deliver on our strategic goals.

At Ionis, we pride ourselves on cultivating a challenging, motivating and rewarding environment that fosters innovation and scientific excellence. We know that our success is a direct result of the exceptional talents and dedication of our employees.

With an unprecedented opportunity to change the course of human health, we look to add diverse individuals, skill sets and perspectives to our exceptional team. We continue to invest time, money and energy into making our onsite, hybrid and remote work environments a place where solid and lasting relationships are built and where our culture and employees can thrive.

We’re building on our rich history, and we believe our greatest achievements are ahead of us. If you’re passionate about the opportunity to have meaningful impact on patients in need, experience and contribute to our unique culture while you develop and expand your career!

Ionis Pharmaceuticals is seeking an experienced Pharmaceutical Development professional with a primary focus on preparation of CMC documents in support of development and late-stage drug product programs. This role is well-suited for an individual who can independently author, coordinate, and defend high-quality CMC content for global regulatory submissions and internal reports, while partnering closely with Pharmaceutical Development, Analytical, Quality, Regulatory CMC, Clinical Supply, Device, Project Management, and external stakeholders.

The ideal candidate will bring strong technical expertise in drug product development, along with excellent scientific writing, cross-functional coordination, and document management skills. This position will focus primarily on dossier and report authoring, with occasional support for routine laboratory execution or other departmental activities as needed. The ability to interpret development, manufacturing, analytical, and stability data with scientific rigor and sound judgment is essential.

The successful candidate will drive progress by synthesizing complex technical information quickly to produce polished regulatory documents that accurately communicate the technical information with strategic clarity. They will proactively elevate the quality and efficiency of CMC authoring across Pharmaceutical Development programs to ensure submissions are accurate, complete, and on time.

• Serve as the primary author and / or coordinator for drug product CMC sections of regulatory submissions and supporting documents, including INDs, IMPDs, NDAs, briefing packages, and responses to regulatory questions.
• Translate technical data from formulation development, drug product / device development and manufacturing, analytical testing, stability studies, specifications, and control strategies into clear, accurate, phase-appropriate regulatory narratives and summaries.
• Partner with Pharmaceutical Development leads and cross-functional CMC teams to define authoring strategy, align messaging across drug product sections, identify data gaps early, and drive document completion within aggressive timelines.
• Lead document planning, content integration, version control, review cycles, comment reconciliation, and finalization of submission-ready CMC documents.
• Author and/or review related technical documents that support regulatory filings, such as development reports, justification documents, protocols,…